Current Opinion in Neurology

Article	Citations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation	71
Management of neuropsychiatric symptoms in dementia	56
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis	53
The recent surge of functional movement disorders: social distress or greater awareness?	42
Chemotherapy and targeted therapies for meningiomas: what is the evidence?	42
Update on management of cerebral venous thrombosis	40
Historical development and contemporary use of neuromodulation in human spinal cord injury	40
The role of the gut microbiome in Alzheimer's disease pathophysiology	40
Hereditary motor neuropathies	38
From basic mechanisms to therapeutic perspectives in cluster headache	37
Editorial introductions	31
Central nervous system adverse events of immune checkpoint inhibitors	29
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies	28
Neurology education in the era of artificial intelligence	28
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	27
Gene therapies for CMT neuropathies: from the bench to the clinic	24
Editorial: Epilepsy advances in 2023	24
T cell dysfunction in glioblastoma: a barrier and an opportunity for the development of successful immunotherapies	24
Microglia in multiple sclerosis – pathogenesis and imaging	24
Equitable partnerships between scientists and persons living with spinal cord injury will strengthen research scope, quality, and outcomes	23
Editorial introductions	22
Development of neural repair therapy for chronic spinal cord trauma: soluble nogo receptor decoy from discovery to clinical trial	21
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise	21
Updates in neuro-otology	20
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection	20

Multiple sclerosis in China: the current state of diagnosis and management	20
Connecting tremors – a circuits perspective	19
Editorial: Modern Gestalt approach to neuromuscular disorders: time for a precision Gestalt	19
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery	18
Thymectomy in myasthenia gravis	18
Threat of resurgence or hope for global eradication of poliovirus?	18
Clinical impact of molecular profiling in rare brain tumors	18
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management	18
Tuberculosis of the central nervous system: current concepts in diagnosis and treatment	18
Migraine in women: a review	17
Revascularization of arterial occlusions in posterior circulation acute ischemic stroke	17
Levodopa infusion therapies for Parkinson disease	17
Burning vertex syndrome: a novel unclassified headache - its preliminary observations, and possible mechanisms	17
Update on the clinical and therapeutic aspects of myotonic dystrophy type 1	17
The FSHD jigsaw: are we placing the tiles in the right position?	17
Idiopathic intracranial hypertension: expanding our understanding	17
fMRI-based spatio-temporal parcellations of the human brain	16
Diet and migraine: what is proven?	16
Gauging and controlling excitability in cortical disorders	16
MRI for the diagnosis of limb girdle muscular dystrophies	16
Editorial: Advances in neuro-oncology: stepping in the right direction	16
Electrical stimulation of the peripheral and central vestibular system	15
Red flags in multiple sclerosis	15
Obesity-related neuropathy: the new epidemic	15
Acute stroke care in low and middle-income countries	15
Parkinson's disease – genetic cause	14
Editorial: The gap between academic advances and therapy development in motor neuron disease	14
Update on dermatomyositis	14
Dysregulation of energy homeostasis in amyotrophic lateral sclerosis	14
Neuromuscular junction disorders beyond myasthenia gravis	13
New developments in diagnostics and treatment of adult-onset focal dystonia	13
Optic neuritis: current challenges in diagnosis and management	13
Neuroinflammation and immunometabolism in neurodegenerative diseases	13
Recent advances in Alzheimer disease genetics	13
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications	13
Novel approaches to treatment of leptomeningeal metastases	13
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis	13
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers	13
Progress in spinal muscular atrophy research	13
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies	13
Targeting IDH1/IDH2 mutations in gliomas	13
Visually induced dizziness	13
Update on genetics of amyotrophic lateral sclerosis	12
Diagnosing viral encephalitis and emerging concepts	12
Recent insights in striated muscle laminopathies	12
The state of art on the use of patient reported outcomes in migraine	12
Monitoring multiple sclerosis: digital and fluid phase biomarkers	12
Fluid phase biomarkers in multiple sclerosis	12
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management	12
Abnormal energy metabolism in ALS: a key player?	12

Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection	11
Editorial: Making the invisible visible: updates on vestibular neurology	11
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health	11
Update on modifiable risk factors for Alzheimer's disease and related dementias	11
Current trend in air pollution exposure and stroke	11
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease	11
Advanced neuroimaging techniques in epilepsy	11
Long COVID and especially headache syndromes	10
Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders	10
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum	10
Pharmacotherapy of cerebellar and vestibular disorders	10
Imaging cortical lesions in multiple sclerosis	10
Muscle ultrasound in myopathies	10
Current gaps in acute reperfusion therapies	10
Editorial: Seizure disorders: 2023 update	10
Progression in multiple sclerosis – a long-term problem	9
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients	9
Immune checkpoint inhibitors induced side effects of the peripheral nervous system	9
Editorial: Innovation and resilience in movement disorders: abundance of creative science despite the covid-19 period	9
Peripheral visual field loss and activities of daily living	9
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review	9
Editorial: Cerebrovascular disease	9
Motion sickness: current concepts and management	9
Mechanisms of coronavirus infectious disease 2019-related neurologic diseases	9
New and emerging pharmacologic treatments for developmental and epileptic encephalopathies	9
Nonneurologic causes of binocular diplopia for the neurologist	9
Update on novel multiple sclerosis treatments: from dismal defeat to scintillating success	8
An update on psychogenic nonepileptic seizures	8
Therapeutic thoroughfares for adults living with Pompe disease	8
Advances in the treatment of neuropathic pain	8
Editorial: Advances in brain tumors management: new perspectives and challenges	8
Interrogating large multiple sclerosis registries and databases: what information can be gained?	8
Multiple sclerosis: advances and challenges in diagnosis	8
Is calcitonin gene-related peptide a reliable biochemical marker of migraine?	8
Progress in treatment of gliomas	8
How to evaluate extent of resection in diffuse gliomas: from standards to new methods	8
Editorial introductions	8
Ménière's disease: new guidelines, subtypes, imaging, and more	8
Assessing the efficacy of duration and intensity prescription for physical activity in mitigating cardiometabolic risk after spinal cord injury	8
Perception and control of a virtual body in immersive virtual reality for rehabilitation	8
Editorial introductions	8
New targets in spontaneous intracerebral hemorrhage	8
Combined neuromodulatory approaches in the central nervous system for treatment of spinal cord injury	7
Lesion network mapping for symptom localization: recent developments and future directions	7
The current landscape of epilepsy genetics: where are we, and where are we going?	7
Barriers to clinical genetic testing in movement disorders	7
Targeting gene fusions in glioma	7
Editorial introductions	7
Vestibular and auditory manifestations of migraine	7
Editorial:Framing artificial intelligence to neuromuscular disorders	7
Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment	7
Artificial intelligence in neuroimaging of brain tumors: reality or still promise?	7
Deep brain stimulation access in 2025: geographic, gender, racial, and socioeconomic disparities re-examined	7
Editorial: Advances in stroke management and upcoming challenges	7
Emerging concepts and therapies for amyotrophic lateral sclerosis	7
Atypical forms of Alzheimer's disease: patients not to forget	7
Shifting our attention earlier in the multiple sclerosis disease course	7
Promises and pitfalls of imaging-based biomarkers in motor neuron diseases	6
Endogenous clues promoting remyelination in multiple sclerosis	6
Headache in infections	6
Socioeconomic disparities in epilepsy care	6
Cancer stem cells in gliomas: evolving concepts and therapeutic implications	6
Editorial introductions	6
New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome	6
Imaging and neuromodulation in Parkinson's disease	6
Ultra-high dose methylcobalamin and other emerging therapies for amyotrophic lateral sclerosis	6
Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications	6
Guillain-Barré syndrome in an era of global infections and 21st century vaccination	6
Editorial: Current opinions in neurology editorial	6
PET-based brain molecular connectivity in neurodegenerative disease	6
Rescue therapies in epilepsy	6
The genetics of amyotrophic lateral sclerosis	6
Medical and neurologic management of brain tumor patients	5
Leprous neuropathy	5
Update on myelin imaging in neurological syndromes	5
Autoimmune nodopathies, an emerging diagnostic category	5
Progress in the mechanism of neuronal surface P antigen modulating hippocampal function and implications for autoimmune brain disease	5
Congenital myasthenic syndromes: increasingly complex	5
Recent insights into haematology and peripheral nerve disease	5
The challenge of amyotrophic lateral sclerosis descriptive epidemiology: to estimate low incidence rates across complex phenotypes in different geographic areas	5

Vestibular syncope	5
Recent advances in epilepsy surgery	5
Editorial introductions	5
Clinical characteristics of patients with myelin oligodendrocyte glycoprotein antibodies	5
The role of caffeine in headache disorders	5
Novel pathophysiological insights in autoimmune myasthenia gravis	5
Ambulatory seizure detection	5
An update on multiple system atrophy	5
Does imaging of the ischemic penumbra have value in acute ischemic stroke with large vessel occlusion?	5
Autoimmune neuromyotonia	5
Editorial: Update on movement disorders	5
Current concepts in acute vestibular syndrome and video-oculography	4
The current clinical perception of myotonic dystrophy type 2	4
Assessment and treatment of neurogenic dysphagia in stroke and Parkinson's disease	4
Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration	4
Somatic mosaicism in focal epilepsies	4
Editorial introductions	4
Systemic vasculitis and headache	4
Current drug treatment of myasthenia gravis	4
Persistent aura without infarction	4
Spasticity following brain and spinal cord injury: assessment and treatment	4
Spinal cord pathology revealed by MRI in traumatic spinal cord injury	4
Promoting exogenous repair in multiple sclerosis: myelin regeneration	4
Imaging of sleep disorders in pre-Parkinsonian syndromes	4
Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease	4
The evolving spectrum of complex inherited neuropathies	4
Recent developments in multiple sclerosis neuropathology	4
Advances in myopathy research: promising developments and challenges	4
Nerve ultrasound for the diagnosis and follow-up of peripheral neuropathies	4
Neuromuscular monitoring devices – where to go next?	4
Recent advances, challenges and perspectives in cerebrovascular disease	4
Defining the presymptomatic phase of frontotemporal dementia	4
Novel trial designs in neuro-oncology	4
Pathomechanisms in demyelination and astrocytopathy: autoantibodies to AQP4, MOG, GFAP, GRP78 and beyond	4
How can you manage an indomethacin-responsive headache in someone who cannot take indomethacin?	3
Describing and assessing behavioural symptoms in amyotrophic lateral sclerosis with and without frontotemporal dementia: a scoping review	3
Late-onset myopathies	3
Reproducibility and replicability in neuroimaging data analysis	3
Parkinson's disease – current treatment	3
Noninvasive brain stimulation to improve motor outcomes after stroke	3
Intravenous thrombolysis for acute ischemic stroke: why not?	3
Noninvasive methods to monitor intracranial pressure	3
Traumatic brachial plexus injury: diagnosis and treatment	3
Editorial: Degenerative and cognitive diseases	3
Updates for newly diagnosed and recurrent glioblastoma: a review of recent clinical trials	3
Sudden unexpected death in epilepsy	3
Editorial: Neuromuscular diseases: differential diagnosis and targeted treatment	3
Re-defining progression in multiple sclerosis	3
Myoclonus: an update	3
Diagnostic criteria for amyotrophic lateral sclerosis	3
Precision medicine in secondary prevention of ischemic stroke: how may blood-based biomarkers help in clinical routine? An expert opinion	3
Recent advances in our understanding of genetic rhabdomyolysis	3
Neuropathology and epilepsy surgery	3
Immunology of multiple sclerosis: an update	3
Peripheral white blood cell responses as emerging biomarkers for patient stratification and prognosis in acute spinal cord injury	3
Neuroscience and oncology: state-of-the-art and new perspectives	3
Epidemiology and genetics of Meniere's disease	3
Advances in functional and structural imaging of the brainstem: implications for disease	3
The atypical faces of optic neuritis: neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease	3